PL4259632T3 - N-(imidazo[1,2-b]pirydazyn-3-ylo)-1-cykloheksylo-2h-indazolo-5-karboksyamid i pochodne n-(pirazolo[1,5-a]pirymidyn-3-ylo)-1-cykloheksylo-2h-indazolo-5-karboksyamidu jako irak4 inhibitory do leczenia astmy - Google Patents
N-(imidazo[1,2-b]pirydazyn-3-ylo)-1-cykloheksylo-2h-indazolo-5-karboksyamid i pochodne n-(pirazolo[1,5-a]pirymidyn-3-ylo)-1-cykloheksylo-2h-indazolo-5-karboksyamidu jako irak4 inhibitory do leczenia astmyInfo
- Publication number
- PL4259632T3 PL4259632T3 PL21836097.2T PL21836097T PL4259632T3 PL 4259632 T3 PL4259632 T3 PL 4259632T3 PL 21836097 T PL21836097 T PL 21836097T PL 4259632 T3 PL4259632 T3 PL 4259632T3
- Authority
- PL
- Poland
- Prior art keywords
- indazolo
- ylo
- carboxamide
- cyclohexyl
- pyridazin
- Prior art date
Links
- 229940127590 IRAK4 inhibitor Drugs 0.000 title 1
- 208000006673 asthma Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063199160P | 2020-12-10 | 2020-12-10 | |
| PCT/EP2021/084916 WO2022122876A1 (en) | 2020-12-10 | 2021-12-09 | N-(imidazo[1,2-b]pyridazin-3-yl)-1-cyclohexyl-2h-indazole-5-carboxamide and n-(pyrazolo[1,5-a]pyrimidin-3-yl)-1-cyclohexyl-2h-indazole-5-carboxamide derivatives as irak4 inhibitors for the treatment of asthma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4259632T3 true PL4259632T3 (pl) | 2024-12-16 |
Family
ID=79230946
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL21836097.2T PL4259632T3 (pl) | 2020-12-10 | 2021-12-09 | N-(imidazo[1,2-b]pirydazyn-3-ylo)-1-cykloheksylo-2h-indazolo-5-karboksyamid i pochodne n-(pirazolo[1,5-a]pirymidyn-3-ylo)-1-cykloheksylo-2h-indazolo-5-karboksyamidu jako irak4 inhibitory do leczenia astmy |
Country Status (32)
| Country | Link |
|---|---|
| US (2) | US11866405B2 (pl) |
| EP (1) | EP4259632B1 (pl) |
| JP (1) | JP7749015B2 (pl) |
| KR (1) | KR20230118153A (pl) |
| AR (1) | AR124303A1 (pl) |
| AU (1) | AU2021395816B2 (pl) |
| CA (1) | CA3203569A1 (pl) |
| CL (1) | CL2023001662A1 (pl) |
| CO (1) | CO2023007624A2 (pl) |
| CR (1) | CR20230264A (pl) |
| DK (1) | DK4259632T3 (pl) |
| DO (1) | DOP2023000119A (pl) |
| EC (1) | ECSP23050553A (pl) |
| ES (1) | ES2989489T3 (pl) |
| FI (1) | FI4259632T3 (pl) |
| HR (1) | HRP20241312T1 (pl) |
| HU (1) | HUE068584T2 (pl) |
| IL (1) | IL303356A (pl) |
| LT (1) | LT4259632T (pl) |
| MA (1) | MA62535B1 (pl) |
| MX (1) | MX2023006816A (pl) |
| PE (1) | PE20240684A1 (pl) |
| PL (1) | PL4259632T3 (pl) |
| PT (1) | PT4259632T (pl) |
| RS (1) | RS66095B1 (pl) |
| SI (1) | SI4259632T1 (pl) |
| SM (1) | SMT202400417T1 (pl) |
| TW (1) | TWI902994B (pl) |
| UA (1) | UA130417C2 (pl) |
| UY (1) | UY39561A (pl) |
| WO (1) | WO2022122876A1 (pl) |
| ZA (1) | ZA202306848B (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20242100A1 (es) * | 2022-02-14 | 2024-10-28 | Astrazeneca Ab | Inhibidores de irak4 |
| AU2023274390A1 (en) * | 2022-05-26 | 2025-01-02 | Astrazeneca Ab | Solid forms of heterocyclylamides as irak4 inhibitors |
| US20240374588A1 (en) | 2023-04-07 | 2024-11-14 | Astrazeneca Ab | Irak4 protacs |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101995013B1 (ko) | 2010-07-13 | 2019-07-02 | 에프. 호프만-라 로슈 아게 | Irak4 조절제로서 피라졸로[1,5a]피리미딘 및 티에노[3,2b]피리미딘 유도체 |
| BR112013015460B1 (pt) | 2010-12-20 | 2022-01-25 | Merck Serono S.A. | Derivados de indazolil triazol, kit, e composição farmacêutica |
| US10029988B2 (en) | 2013-03-15 | 2018-07-24 | Biomarin Pharmaceutical Inc. | HDAC inhibitors |
| US10160753B2 (en) | 2014-01-10 | 2018-12-25 | Aurigene Discovery Technologies Limited | Indazole compounds as IRAK4 inhibitors |
| DK3126330T3 (en) | 2014-04-04 | 2019-04-23 | Pfizer | BICYCLE-FUSED HETEROARYL OR ARYL COMPOUNDS AND USE THEREOF AS IRAC4 INHIBITORS |
| JO3705B1 (ar) | 2014-11-26 | 2021-01-31 | Bayer Pharma AG | إندازولات مستبدلة جديدة، عمليات لتحضيرها، مستحضرات دوائية تحتوي عليها واستخدامها في إنتاج أدوية |
| TW201701879A (zh) | 2015-04-30 | 2017-01-16 | 拜耳製藥公司 | Ｉｒａｋ４抑制劑組合 |
| BR112018000635A2 (pt) | 2015-07-15 | 2018-09-18 | Aurigene Discovery Tech Ltd | compostos aza substituídos como inibidores irak-4 |
| HK1249509A1 (zh) * | 2015-07-15 | 2018-11-02 | Aurigene Discovery Technologies Limited | 作为irak-4抑制剂的吲唑及氮杂吲唑化合物 |
| WO2017108723A2 (en) * | 2015-12-22 | 2017-06-29 | F. Hoffmann-La Roche Ag | PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS |
| US10435396B2 (en) | 2016-03-03 | 2019-10-08 | Bayer Pharma Aktiegesellschaft | 2-substituted indazoles, methods for producing same, pharmaceutical preparations that contain same, and use of same to produce drugs |
| US10059708B2 (en) | 2016-04-26 | 2018-08-28 | Northwestern University | Therapeutic targeting of the interleukin 1 receptor-associated kinase 4 (IRAK4) in leukemias characterized by rearrangements in the mixed lineage leukemia gene (MLL-r) |
| AU2017273771B2 (en) | 2016-06-01 | 2022-09-29 | Bayer Pharma Aktiengesellschaft | Use of 2-substituted indazoles for the treatment and prophylaxis of autoimmune diseases |
| JP2020524692A (ja) | 2017-06-21 | 2020-08-20 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | Ｉｒａｋ４調節因子としてのベンゾフラン |
| EP3642201A1 (en) | 2017-06-21 | 2020-04-29 | H. Hoffnabb-La Roche Ag | Isoindolinone derivatives as irak4 modulators |
| UY38765A (es) | 2019-06-27 | 2021-01-29 | Biogen Ma Inc | Derivados de 2h-indazol y su uso en el tratamiento de enfermedades |
| EP3990454A1 (en) | 2019-06-27 | 2022-05-04 | Biogen MA Inc. | Imidazo[1,2-a]pyridinyl derivatives and their use in the treatment of disease |
-
2021
- 2021-12-01 US US17/457,249 patent/US11866405B2/en active Active
- 2021-12-09 PL PL21836097.2T patent/PL4259632T3/pl unknown
- 2021-12-09 WO PCT/EP2021/084916 patent/WO2022122876A1/en not_active Ceased
- 2021-12-09 CA CA3203569A patent/CA3203569A1/en active Pending
- 2021-12-09 LT LTEPPCT/EP2021/084916T patent/LT4259632T/lt unknown
- 2021-12-09 HU HUE21836097A patent/HUE068584T2/hu unknown
- 2021-12-09 DK DK21836097.2T patent/DK4259632T3/da active
- 2021-12-09 UA UAA202303173A patent/UA130417C2/uk unknown
- 2021-12-09 PE PE2023001857A patent/PE20240684A1/es unknown
- 2021-12-09 FI FIEP21836097.2T patent/FI4259632T3/fi active
- 2021-12-09 MX MX2023006816A patent/MX2023006816A/es unknown
- 2021-12-09 MA MA62535A patent/MA62535B1/fr unknown
- 2021-12-09 ES ES21836097T patent/ES2989489T3/es active Active
- 2021-12-09 EP EP21836097.2A patent/EP4259632B1/en active Active
- 2021-12-09 CR CR20230264A patent/CR20230264A/es unknown
- 2021-12-09 HR HRP20241312TT patent/HRP20241312T1/hr unknown
- 2021-12-09 IL IL303356A patent/IL303356A/en unknown
- 2021-12-09 SI SI202130206T patent/SI4259632T1/sl unknown
- 2021-12-09 AU AU2021395816A patent/AU2021395816B2/en active Active
- 2021-12-09 PT PT218360972T patent/PT4259632T/pt unknown
- 2021-12-09 RS RS20241183A patent/RS66095B1/sr unknown
- 2021-12-09 KR KR1020237023107A patent/KR20230118153A/ko active Pending
- 2021-12-09 SM SM20240417T patent/SMT202400417T1/it unknown
- 2021-12-09 JP JP2023535016A patent/JP7749015B2/ja active Active
- 2021-12-09 TW TW110145977A patent/TWI902994B/zh active
- 2021-12-10 UY UY0001039561A patent/UY39561A/es unknown
- 2021-12-10 AR ARP210103432A patent/AR124303A1/es unknown
-
2023
- 2023-06-08 CL CL2023001662A patent/CL2023001662A1/es unknown
- 2023-06-09 CO CONC2023/0007624A patent/CO2023007624A2/es unknown
- 2023-06-09 DO DO2023000119A patent/DOP2023000119A/es unknown
- 2023-07-05 ZA ZA2023/06848A patent/ZA202306848B/en unknown
- 2023-07-05 EC ECSENADI202350553A patent/ECSP23050553A/es unknown
- 2023-11-02 US US18/500,155 patent/US12448385B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL4259632T3 (pl) | N-(imidazo[1,2-b]pirydazyn-3-ylo)-1-cykloheksylo-2h-indazolo-5-karboksyamid i pochodne n-(pirazolo[1,5-a]pirymidyn-3-ylo)-1-cykloheksylo-2h-indazolo-5-karboksyamidu jako irak4 inhibitory do leczenia astmy | |
| IL281127A (en) | Pyrazolo[3,4-b]pyridine compounds as inhibitors of tam and met kinases | |
| MX388140B (es) | Compuestos de pirazolo[1,5-a]piridina sustituidos como inhibidores de la quinasa ret. | |
| EP3873900C0 (en) | IMIDAZO[1,2-A]PYRIDINE DERIVATIVES AS INTEGRIN ALPHA4BETA7 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES | |
| TN2019000110A1 (en) | Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitors | |
| NZ766835A (en) | Pharmaceutical compounds | |
| EP3976607A4 (en) | PYRROLO[2,3-B]PYRIDINE AND PYRAZOLO[3,4-B]PYRIDINE SUBSTITUTED DERIVATIVES AS PROTEIN KINASE INHIBITORS | |
| HUE064667T2 (hu) | Pirido[3',4':4,5]pirrolo[1,2,3-de]kinoxalin származékok központi idegrendszeri betegségek kezelésében történõ alkalmazásra | |
| EP3842431C0 (en) | COMPOUND [1,2,4]TRIAZOLO[1,5-A]PYRIDINE USED AS JAK INHIBITOR AND USE THEREOF | |
| NO20082414L (no) | Inhibitorer av AKT-aktivitet | |
| PT1948654E (pt) | Derivados da 5-amino-4-hidroxi-7-(imidazo[1,2-a] piridin-6-ilmetil)-8-metil-nonamida e compostos relacionados como inibidores da renina para o tratamento da hipertensão | |
| MX2010002295A (es) | Formas solidas que comprenden n-(5-ter-butil-isoxazol-3-il)-n´-{4- [7-(2-morfolin-4-il-etoxi) imidazo [2,1-b]-[1,3] benzotiazol-2-il] fenil} urea, composiciones de las mismas, y usos de las mismas. | |
| NO20072046L (no) | Halogensubstituerte benzodiazepinderivater | |
| CA3266687A1 (en) | PYRAZOLO[1,5-A]PYRIDINE AND IMIDAZO[1,2-A]PYRIDINE DERIVATIVES AS FGFR3 INHIBITORS FOR CANCER TREATMENT | |
| IL283823A (en) | 7-phenoxy-n-(3-azabicyclo[3.2.1]octan-8-yl)-6,7-dihydro-5h-pyrrolo[1,2-b][1,2,4]triazol-2-amine derivatives and related compounds as gamma-secretase modulators for the treatment of alzheimer's disease | |
| JOP20200311A1 (ar) | مثبطات صغيرة الجزيئات من فئة الكينازات مزدوجة الوجه (jak) | |
| IL276901A (en) | History of 10-(di(phenyl)methyl)-4-hydroxy-8,9,10,9A-tetrahydro-H7-pyrrolo[1',2':4,5]pyrazino[1,2-B]pyridazine-3 5-Dion and related compounds as inhibitors of orthomyxovirus replication for the treatment of influenza | |
| ZA202102974B (en) | 2,6-dimethyl-n-((pyridin-4-yl)methyl)imidazo[1,2-b]pyridazin-8-amine and 2,5-dimethyl-n-[(pyridin-4-yl)methyl]pyrazolo[1,5-a]pyrimidin-7-amine derivatives for treating viral infections | |
| MX2023005761A (es) | Pirrolo [2,3-b] piridina sustituida y derivados de pirazolo [3,4-b] piridina como inhibidores de proteinas quinasas. | |
| EA201990940A1 (ru) | ЗАМЕЩЕННЫЕ ПИРАЗОЛО[1,5-a]ПИРИДИНОВЫЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ RET КИНАЗЫ | |
| HK40102603A (en) | Imidazo[1,2-a]pyridine derivatives as irak4 inhibitors and their use in the treatment of disease | |
| EP4499636A4 (en) | PYRAZOLO[1,5-A]PYRIDINE DERIVATIVES FOR THE TREATMENT OF TRPM3 MEDIATED DISORDERS | |
| HK40103397A (en) | Substituted pyrazolo[1,5-a]pyrimidine-7-amine compounds as cdk inhibitors and their therapeutic use | |
| HK40064762A (en) | Imidazo[1,2-a]pyridinyl derivatives as irak4 inhibitors | |
| EA202190393A1 (ru) | СОЕДИНЕНИЯ ПИРАЗОЛО[3,4-b]ПИРИДИНА В КАЧЕСТВЕ ИНГИБИТОРОВ TAM- И Met-КИНАЗ |